52 related articles for article (PubMed ID: 34003771)
1. Microbe-based therapies for colorectal cancer: Advantages and limitations.
Saeed M; Shoaib A; Kandimalla R; Javed S; Almatroudi A; Gupta R; Aqil F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):652-665. PubMed ID: 34020027
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy de-escalation using an
Pérez-García JM; Gebhart G; Ruiz Borrego M; Stradella A; Bermejo B; Schmid P; Marmé F; Escrivá-de-Romani S; Calvo L; Ribelles N; Martinez N; Albacar C; Prat A; Dalenc F; Kerrou K; Colleoni M; Afonso N; Di Cosimo S; Sampayo-Cordero M; Malfettone A; Cortés J; Llombart-Cussac A;
Lancet Oncol; 2021 Jun; 22(6):858-871. PubMed ID: 34019819
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance.
Liu Y; Yang K; Jia Y; Shi J; Tong Z; Fang D; Yang B; Su C; Li R; Xiao X; Wang Z
Nat Microbiol; 2021 Jul; 6(7):874-884. PubMed ID: 34017107
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Pyrotinib Versus T-DM1 in HER2+ Metastatic Breast Cancer Patients Pre-Treated With Trastuzumab and a Taxane: A Bayesian Network Meta-Analysis.
Liao H; Huang W; Liu Y; Pei W; Li H
Front Oncol; 2021; 11():608781. PubMed ID: 34012912
[TBL] [Abstract][Full Text] [Related]
5. Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Hofheinz RD; Hegewisch-Becker S; Kunzmann V; Thuss-Patience P; Fuchs M; Homann N; Graeven U; Schulte N; Merx K; Pohl M; Held S; Keller R; Tannapfel A; Al-Batran SE
Int J Cancer; 2021 Sep; 149(6):1322-1331. PubMed ID: 34019698
[TBL] [Abstract][Full Text] [Related]
6. HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now.
Schlam I; Swain SM
NPJ Breast Cancer; 2021 May; 7(1):56. PubMed ID: 34016991
[TBL] [Abstract][Full Text] [Related]
7. NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
Ganz PA; Cecchini RS; Fehrenbacher L; Geyer CE; Rastogi P; Crown JP; Thirlwell MP; Ellison DM; Boileau JF; Flynn PJ; Jeong JH; Mamounas EP; Wolmark N
NPJ Breast Cancer; 2021 May; 7(1):55. PubMed ID: 34016989
[TBL] [Abstract][Full Text] [Related]
8. The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment.
Kim SH; Lim YJ
Intest Res; 2022 Jan; 20(1):31-42. PubMed ID: 34015206
[TBL] [Abstract][Full Text] [Related]
9. Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial.
van der Voort A; van Ramshorst MS; van Werkhoven ED; Mandjes IA; Kemper I; Vulink AJ; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS
JAMA Oncol; 2021 Jul; 7(7):978-984. PubMed ID: 34014249
[TBL] [Abstract][Full Text] [Related]
10. The Hippo-TAZ axis mediates vascular endothelial growth factor C in glioblastoma-derived exosomes to promote angiogenesis.
Wang Z; Yuan Y; Ji X; Xiao X; Li Z; Yi X; Zhu Y; Guo T; Wang Y; Chen L; Liu Y
Cancer Lett; 2021 Aug; 513():1-13. PubMed ID: 34010715
[TBL] [Abstract][Full Text] [Related]
11. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
Huang J; Liu D; Wang Y; Liu L; Li J; Yuan J; Jiang Z; Jiang Z; Hsiao WW; Liu H; Khan I; Xie Y; Wu J; Xie Y; Zhang Y; Fu Y; Liao J; Wang W; Lai H; Shi A; Cai J; Luo L; Li R; Yao X; Fan X; Wu Q; Liu Z; Yan P; Lu J; Yang M; Wang L; Cao Y; Wei H; Leung EL
Gut; 2022 Apr; 71(4):734-745. PubMed ID: 34006584
[TBL] [Abstract][Full Text] [Related]
12. The effect of pre-operative intake of oral water and ranitidine on gastric fluid volume and pH in children undergoing elective surgery.
Gombar S; Dureja J; Kiran S; Gombar K; Chhabra B
J Indian Med Assoc; 1997 Jun; 95(6):166-8. PubMed ID: 9420391
[TBL] [Abstract][Full Text] [Related]
13. The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Nandi D; Parida S; Sharma D
Gut Microbes; 2023; 15(1):2221452. PubMed ID: 37305949
[TBL] [Abstract][Full Text] [Related]
14. Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha C; Peng Z; Huang K; Tang K; Wang Q; Zhu L; Che B; Li W; Xu S; Huang T; Yu Y; Zhang W
Front Oncol; 2023; 13():1196217. PubMed ID: 37265797
[TBL] [Abstract][Full Text] [Related]
15. Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis.
Thu MS; Chotirosniramit K; Nopsopon T; Hirankarn N; Pongpirul K
Front Oncol; 2023; 13():1144021. PubMed ID: 37007104
[TBL] [Abstract][Full Text] [Related]
16. Towards Taming the Bugs to Improve the Drugs for Breast Cancer.
Sharma D
Cancer Res; 2021 Apr; 81(8):1937-1939. PubMed ID: 34003771
[TBL] [Abstract][Full Text] [Related]
17. Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models.
Gonzalez-Alonso P; Cristobal I; Zazo S; Martin-Aparicio E; Chamizo C; Madoz-Gurpide J; Rovira A; Eroles P; Lluch A; Albanell J; Rojo F
Curr Med Chem; 2018; 25(17):1976-1998. PubMed ID: 27993109
[TBL] [Abstract][Full Text] [Related]
18. Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.
Zardavas D; Fouad TM; Piccart M
Breast; 2015 Nov; 24 Suppl 2():S143-8. PubMed ID: 26255196
[TBL] [Abstract][Full Text] [Related]
19. Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China.
Li J; Wang S; Wang Y; Wang X; Wang H; Feng J; Zhang Q; Sun T; Ouyang Q; Yin Y; Liu Y; Geng C; Yan M; Jiang Z
Oncologist; 2017 Nov; 22(11):1333-1338. PubMed ID: 28798274
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
